Skip to main content
Fig. 4 | Journal of Medical Case Reports

Fig. 4

From: Atezolizumab in combination with intrathecal chemotherapy and radiation for treatment of isolated cerebral nervous system relapse in a patient with extranodal NK/T cell lymphoma: a case report

Fig. 4

Atypical lymphocytes in the CSF during treatment with atezolizumab and triple intrathecal (TIT) chemotherapy following second relapse. At the patient’s second relapse, atypical lymphocytes were elevated at 1550. With atezolizumab infusion and TIT chemotherapy, the atypical lymphocyte count dropped significantly and remained very low over the course of the treatment

Back to article page

Journal of Medical Case Reports

ISSN: 1752-1947